Apnicaf Oral Solution is a prescription medicine used in the treatment of apnea (a disorder in which breathing repeatedly stops and starts) of prematurity. It facilitates normal breathing and reduces interrupted breathing in premature newborns.
Apnicaf Oral Solution is given under the supervision of healthcare professionals. It is given by mouth or via a gastric feeding tube only. Remember, if you are breastfeeding while your infant is treated with this medicine, then do not drink coffee or take any other high caffeine product as this passes into breast milk.
Some common side effects of using this medicine are restlessness, insomnia, headaches, dizziness, increased heart rate. Consult your doctor if these persist for a longer duration or get worse. They may be able to suggest ways to prevent or reduce these side effecrts.
Uses:
Apnea of prematurity
Directions For Use:
Take this medicine in the dose and duration as advised by your doctor. Check the label for directions before use. Measure it with a measuring cup and take it by mouth. Shake well before use. Apnicaf Oral Solution may be taken with or without food.
Side Effects:
Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them
Ordinary side effects of Apnicaf
Restlessness
Headache
Insomnia (difficulty in sleeping)
Dizziness
Increased heart rate
Warning & Precautions:
Alcohol
UNSAFE
It is unsafe to consume alcohol with Apnicaf Oral Solution
Pregnancy
CONSULT YOUR DOCTOR
The safety of Apnicaf Oral Solution during pregnancy has not been established. There are no adequate and well-controlled studies in pregnant women, and animal data on reproductive toxicity are insufficient. Your doctor will weigh the benefits and any potential risks before prescribing.
Breast feeding
CAUTION
Apnicaf Oral Solution should be used with caution during breastfeeding. Breastfeeding should be held until the treatment of the mother is completed and the drug is eliminated from the body.
Driving
UNSAFE
Apnicaf Oral Solution may decrease alertness, affect your vision, or make you feel sleepy and dizzy. Do not drive if these symptoms occur.
Kidney
CONSULT YOUR DOCTOR
There is limited data available on the use of Apnicaf Oral Solution in patients with kidney disease. Please consult your doctor.
Liver
CONSULT YOUR DOCTOR
There is limited data available on the use of Apnicaf Oral Solution in patients with liver disease.
FAQs:
What is Apnicaf Oral Solution and why is it used in newborns?
Apnicaf Oral Solution is a medicine given to premature babies who have apnea of prematurity. This condition causes infants to stop breathing for short periods because their breathing system is not fully developed. The medicine helps stimulate the baby’s brain and lungs to improve breathing.
How does Apnicaf Oral Solution work in premature babies?
Apnicaf Oral Solution works by stimulating the central nervous system and the baby’s breathing center. It makes the brain more responsive to carbon dioxide and helps reduce episodes where the baby stops breathing. It also improves muscle tone and decreases fatigue of the diaphragm, the muscle that controls breathing.
Who should not receive Apnicaf Oral Solution?
Apnicaf Oral Solution should not be given to infants who are allergic or hypersensitive to caffeine, or any of the ingredients in the medicine. If a baby has shown any allergic reaction to caffeine in the past, this medicine should be avoided.
What serious risks are linked with Apnicaf Oral Solution in newborns?
One of the most serious risks linked to Apnicaf Oral Solution is necrotizing enterocolitis (a life-threatening bowel condition), which has been reported in premature babies during clinical studies. Because of this, babies receiving this medicine must be closely monitored for abdominal bloating, vomiting, bloody stools, unusual sleepiness, or sudden changes in energy levels.
Can Apnicaf Oral Solution be used for long-term treatment?
No, Apnicaf Oral Solution is meant only for short-term treatment of apnea of prematurity, typically for 10 to 12 days. Its safety and effectiveness for long-term use, or for other conditions such as sudden infant death syndrome (SIDS), have not been proven.
What precautions should doctors take before giving Apnicaf Oral Solution?
Earlier starting Apnicaf Oral Solution treatment, doctors should rule out other possible causes of apnea, such as infections, anemia, or lung disease. They may also need to check caffeine levels in babies who were previously given theophylline, or whose mothers consumed caffeine before delivery, since these can affect blood caffeine levels.
What should caregivers watch for while their baby is on Apnicaf Oral Solution?
While the baby is on Apnicaf Oral Solution treatment, parents or caregivers should immediately contact the doctor if the baby develops a swollen belly, vomiting, bloody stools, unusual sleepiness, or seems unwell. These may be signs of serious complications such as necrotizing enterocolitis.
Written by:
Dr. Lokanish
M.B.B.S.
Reviewed by:
Dr. Sureshbabu Yadav
M.B.B.S., DIP.DIAB, F.R.S.H
Disclaimer:
Getomeds primary intention is to ensure that its consumers get information that is reviewed by experts, accurate, and trustworthy. The information and contents of this website are for informational purposes only. They are not intended to be a substitute for professional medical advice, diagnosis, or treatment. Please seek the advice of your doctor and discuss all of your concerns about any disease or medication. Do not disregard or postpone seeking professional medical advice because of something you read on Getomeds. Our mission is to support, not replace, the doctor-patient relationship.